This website provides a curated collection of resources about the people, places and technologies that have enabled biotechnology to transform our healthcare and the world we live in today

Timeline of key events

genetics: Timeline of key events

To search for particular terms in the description of the event enter the term in the box below 'Event' on the table and press 'enter'. Alternatively use the dropdown lists to filter by Person, Place or Science. Click here to clear the filter.

Date Event People Places Sciences
Feb 2005Enzyme Ubp10 demonstrated to protect the genome from potential destabilising molecular eventsBerger, EmreWistar InstituteDNA, Genetics
2006FDA approved second DNA methylation inhibitior, decatabine (Dacogen)  DNA methylation, Epigenetics
06 Oct 2006FDA approved first histone deacetylase inhibitor, Vorinostat (Zolinza), for cutaneous T-cell lymphoma  Epigenetics, Oncology
11 Nov 2006Esther Lederberg diedLederbergWisconsin UniversityGenetics, Antimicrobial resistance, Bacteriophages, Lambda phage
26 Oct 2007Arthur Kornberg diedKornbergStanford UniversityGenetics, DNA, RNA
2008Structure of telomerase, an enzyme that conserves the ends of chomosomes, was decoded Wistar InstituteDNA, genetics
02 Feb 2008Joshua Lederberg diedLederbergUniversity of WisconsinGenetics, Plasmids
Nov 2009FDA approved second histone deactylase inhibitor, Romidepsin (Istodax), for cutaneous T-cell lymphoma   Epigenetics, Oncology
15 Jan 2010Marshall W Nirenberg diedNirenbergNational Institutes of HealthGenetics
09 Nov 2011Har Gobind Khorana diedKhoranaConcord, Massachusetts, USAGenetics
03 Feb 2012Norton David Zinder diedZinderRockefeller UniversityGenetics
19 Feb 2012Renato Dulbecco diedDulbeccoImperial Cancer Research Fund LaboratoryGenetics, Virology, Oncology
2012European approval of decatabine (Dacogen) for treatment of acute myeloid leukaemia  Epigenetics, Oncology
19 Apr 2013Francois Jacob diedJacobPasteur InstituteGenetics
Apr 2015Chinese regulatory authorities approved Chidamide, a histone deactylase inhibitor, for peripheral T cell lymphoma  Epigenetics, Oncology
27 Aug 2015Experiments with mice showed that azacytidine treatment enhanced the responsiveness of tumors to anti–CTLA-4 therapy  Cancer immunotherapy, Epigenetics, Immune checkpoint inhibitors, Oncology

Website design by Silico Research the creative minds behind BioPartnering.

Follow us to keep up with all the new content about the world of biotechnology.